{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:15Z","timestamp":1786985055604,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002424","name":"Fujifilm Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbrc.2023.149356","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T11:21:45Z","timestamp":1701861705000},"page":"149356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies"],"prefix":"10.1016","volume":"692","author":[{"given":"Yuki","family":"Imakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Mima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2837-7946","authenticated-orcid":false,"given":"Nao","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamihide","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.149356_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-015-0351-6","article-title":"Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models","volume":"55","author":"Peters","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2023.149356_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/17425255.2013.802772","article-title":"Experimental models for predicting drug absorption and metabolism","volume":"9","author":"Alqahtani","year":"2013","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2023.149356_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1271\/bbb.90730","article-title":"Interaction between food substances and the intestinal epithelium","volume":"74","author":"Shimizu","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrc.2023.149356_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-801238-3.10923-7","article-title":"Pathophysiological mechanisms of gastrointestinal toxicity","author":"Gelberg","year":"2018","journal-title":"Compr. Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2023.149356_bib5","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1079\/BJN19980108","article-title":"Functional food science and gastrointestinal physiology and function","volume":"80","author":"Salminen","year":"1998","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbrc.2023.149356_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13619-022-00118-7","article-title":"Cross-species single-cell transcriptomic analysis reveals divergence of cell composition and functions in mammalian ileum epithelium","volume":"11","author":"Li","year":"2022","journal-title":"Cell Regen."},{"key":"10.1016\/j.bbrc.2023.149356_bib7","first-page":"280","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2023.149356_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbrc.2023.149356_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2023.149356_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1023\/A:1012102522787","article-title":"In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth","volume":"14","author":"Yee","year":"1997","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.bbrc.2023.149356_bib11","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.bbrc.2023.149356_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2023.149356_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S2225-4110(16)30080-3","article-title":"Modulation of intestinal functions by dietary substances: an effective approach to health promotion","volume":"2","author":"Shimizu","year":"2012","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.bbrc.2023.149356_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(95)04204-0","article-title":"Comparison between active and passive drug transport in human intestinal epithelial (caco-2) cells in vitro and human jejunum in vivo","volume":"127","author":"Lennern\u00e4s","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2023.149356_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/dmd.30.1.4","article-title":"Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas","volume":"30","author":"Nakamura","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1472-8206.2007.00550.x","article-title":"Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR","volume":"21","author":"Maubon","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149356_bib17","first-page":"383","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2023.149356_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1124\/dmd.112.050500","article-title":"Variability in P-glycoprotein inhibitory potency (IC\u2085\u2080) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria","volume":"41","author":"Bentz","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/dmd.116.074377","article-title":"Human enterocytes as an in vitro model for the evaluation of intestinal drug metabolism: characterization of drug-metabolizing enzyme activities of cryopreserved human enterocytes from twenty-four donors","volume":"45","author":"Ho","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/dmd.120.000138","article-title":"Characterization of the human intestinal drug transport with ussing chamber system incorporating freshly isolated human jejunum","volume":"49","author":"Michiba","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425255.2016.1125882","article-title":"Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research","volume":"12","author":"Li","year":"2016","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2023.149356_bib22","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2023.149356_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2023.149356_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/stem.1344","article-title":"Wnt and Notch signals guide embryonic stem cell differentiation into the intestinal lineages","volume":"31","author":"Ogaki","year":"2013","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2023.149356_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2133\/dmpk.DMPK-13-RG-005","article-title":"Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method","volume":"29","author":"Iwao","year":"2014","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2023.149356_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/dmd.114.062604","article-title":"Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds","volume":"43","author":"Iwao","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep17297","article-title":"A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells","volume":"5","author":"Ogaki","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.149356_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep16479","article-title":"Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine","volume":"5","author":"Ozawa","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.149356_bib29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.stemcr.2018.10.019","article-title":"Efficient generation of small intestinal epithelial-like cells from human iPSCs for drug absorption and metabolism studies","volume":"11","author":"Negoro","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2023.149356_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dmpk.2020.04.334","article-title":"Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells","volume":"35","author":"Kabeya","year":"2020","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2023.149356_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.stemcr.2020.12.017","article-title":"Generation of human-induced pluripotent stem cell-derived functional enterocyte-like cells for pharmacokinetic studies","volume":"16","author":"Yoshida","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2023.149356_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2023.149356_bib34","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.149356_bib35","first-page":"819","article-title":"Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon","volume":"20","author":"Collins","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.bbrc.2023.149356_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep36776","article-title":"Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury","volume":"6","author":"Lepage","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.149356_bib37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1186\/1756-0500-7-902","article-title":"Characterization of the developing small intestine in the absence of either GATA4 or GATA6","volume":"7","author":"Walker","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bbrc.2023.149356_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/annonc\/mdn579","article-title":"Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients","volume":"20","author":"Derikx","year":"2009","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.bbrc.2023.149356_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/pr.2014.89","article-title":"Intestinal fatty acid-binding protein: a possible marker for gut maturation","volume":"76","author":"Reisinger","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbrc.2023.149356_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1293\/tox.11.177","article-title":"Prolonged effect of 5-fluorouracil and its derivatives on apoptosis induction and mitotic inhibition in the intestinal epithelium of male DBF1 mice","volume":"11","author":"Inomata","year":"1998","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.bbrc.2023.149356_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2010.01.023","article-title":"Homeostasis and inflammation in the intestine","volume":"140","author":"Garrett","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2023.149356_bib42","series-title":"Co-culture Caco-2\/Immune Cells","first-page":"197","author":"Kleiveland","year":"2015"},{"key":"10.1016\/j.bbrc.2023.149356_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.277.5328.949","article-title":"Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria","volume":"277","author":"Kern\u00e9is","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2023.149356_bib44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2000.4038","article-title":"Expression of specific markers and particle transport in a new human intestinal M-cell model","volume":"279","author":"Gullberg","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2023.149356_bib45","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nprot.2017.041","article-title":"A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation","volume":"12","author":"Beloqui","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2023.149356_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18115833","article-title":"Acute and sub-chronic effects of microplastics (3 and 10 \u03bcm) on the human intestinal cells HT-29","volume":"18","author":"Visalli","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.bbrc.2023.149356_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discov. Today"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2301450X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2301450X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:38:42Z","timestamp":1757767122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2301450X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"alternative-id":["S0006291X2301450X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149356","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"149356"}}